Literature DB >> 8069234

Slow-binding inhibition of sialidase from influenza virus.

M S Pegg1, M von Itzstein.   

Abstract

Sialidase from influenza virus A (Tokyo/3/67, N2) is inhibited in slow-binding fashion by 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid. The Ki observed for the tightly-bound form at steady-state is 3 x 10(-11) M. Slow-binding, which is a consequence of the guanidinyl moiety of the inhibitor, is observed only for influenza virus A sialidase and not for influenza virus B or any other viral, bacterial, or mammalian sialidase investigated. The different results obtained for sialidases from influenza virus A and B, whose active sites are conserved, point to the involvement of the expulsion of a structural water molecule in the slow-binding mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8069234

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  12 in total

1.  Solid phase assay for comparing reactivation rates of neuraminidases of influenza wild type and resistant mutants after inhibitor removal.

Authors:  Susan Barrett; Jennifer L McKimm-Breschkin
Journal:  Antiviral Res       Date:  2014-05-20       Impact factor: 5.970

2.  A structural and energetics analysis of the binding of a series of N-acetylneuraminic-acid-based inhibitors to influenza virus sialidase.

Authors:  N R Taylor; M von Itzstein
Journal:  J Comput Aided Mol Des       Date:  1996-06       Impact factor: 3.686

Review 3.  Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.

Authors:  Jennifer L McKimm-Breschkin
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

4.  Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir.

Authors:  Michael Z Wang; Chun Y Tai; Dirk B Mendel
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.

Authors:  J N Varghese; V C Epa; P M Colman
Journal:  Protein Sci       Date:  1995-06       Impact factor: 6.725

6.  Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses.

Authors:  Aaron J Oakley; Susan Barrett; Thomas S Peat; Janet Newman; Victor A Streltsov; Lynne Waddington; Takehiko Saito; Masato Tashiro; Jennifer L McKimm-Breschkin
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

Review 7.  New approaches to influenza chemotherapy. Neuraminidase inhibitors.

Authors:  D P Calfee; F G Hayden
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

8.  Combining crystallographic information and an aspherical-atom data bank in the evaluation of the electrostatic interaction energy in an enzyme-substrate complex: influenza neuraminidase inhibition.

Authors:  Paulina M Dominiak; Anatoliy Volkov; Adam P Dominiak; Katarzyna N Jarzembska; Philip Coppens
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-04-18

9.  Rapid analysis of O-acetylated neuraminic acids by matrix assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  P Stehling; M Gohlke; R Fitzner; W Reutter
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

Review 10.  Influenza virus neuraminidase: structure, antibodies, and inhibitors.

Authors:  P M Colman
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.